Skip to main content

Table 1 Sociodemographic, comorbidities and biochemical characteristics of the study sample

From: Clinical malaria and the potential risk of anaemia among preschool-aged children: a population-based study of the 2015–2016 Malawi micronutrient survey

Variable

Frequency

n = 1051

Percent

(%)

Sex

 Female

539

49.18

 Male

512

50.82

Age (months)

 6–11

97

9.43

 12–23

221

21.77

 24–35

257

25.29

 36–47

264

24.00

 48–59

212

19.52

Fever in last 2 weeks

 Yes

505

43.25

 No

546

56.75

Malaria test result

 Positive

278

27.63

 Negative

773

72.37

Clinical malariaa

 Yes

271

27.37

 No

780

72.63

Alpha1-Acid Glycoprotein

 Normal

443

44.33

 Abnormal

608

55.67

Serum ferritinb

 Normal

835

78.29

 Abnormal

216

21.71

G6PD (n = 1004)

 Unaffected

723

72.08

 Affected

118

11.76

 Carrier

162

16.15

Alpha-thalassemia (n = 999)

 Unaffected

609

60.96

 Affected

80

8.01

 Carrier

310

31.03

Household hunger scale

 Little to none

485

39.98

 Moderate to severe

566

60.02

Type of place of residence

 Urban

117

10.03

 Rural

934

89.97

Region of residence

 North

372

13.82

 Central

383

44.34

 Southern

296

41.84

Outcome variable

Any anemia

  < 110 g/L

742

70.96

  ≥ 110 g/L

309

29.04

  1. G6PD Glucose-6-phosphate dehydrogenase
  2. aDefined as an individual with malaria-related symptoms (fever [axillary temperature ≥ 37.5 °C], chills, severe malaise, headache or vomiting) at the time of examination or 1–2 days prior to the examination in the presence of a Plasmodium falciparum positive blood smear; bSerum ferritin adjusted for inflammation using internal regression approach, malaria test using a rapid diagnostic test (RDT) kit the Standard Diagnostic (SD) BIOLINE Malaria Ag P.f/Pan histamine-rich protein (HRP-II)™ RDT)